Ovulographic™ Technology

Slides:



Advertisements
Similar presentations
Instruction: Use mouses left button. Use mouses left button. If mouse buttons dont work, use arrow keys of keyboard for slide show. If mouse buttons dont.
Advertisements

Instruction: Use mouses left button. Use mouses left button. If mouse buttons dont work, use arrow keys of keyboard for slide show. If mouse buttons dont.
Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) Transforming Female Reproductive Health.
All actions in PADDS begin with setting up the patient.
Usually the next step is to run the Cognitive Tests. Click on “Run Cognitive Tests” button to start testing. All of the tests begin with you giving a brief.
RRMC RITE Training for Physicians and Physician Extenders Part 3: Daily Rounding and Progress Notes The presentations should open full screen in “Show.
© Commonwealth of Australia 2009 Laptops and Windows tips.
Completing a CMS-2728 Form in CROWNWeb
BioZhena Corporation 5/13/ Private Placement Offering and/or Strategic Alliance Proposal bioZhena Corporation.
Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) Transforming Female Reproductive Health.
. © 2003 Ownership Associates < Go back Advance > OA INC Using E-Learning Tools From Ownership Associates, Inc.
The Nature of Disease.
Course 6: Client Intake 2 ARIES ON DEMAND Training 6.00.
Marquette University trial confirmed Turin results – this time with non-baseline subjects (as in real life). R.J. Fehring and W.D. Schlaff, J. Nurse-Midwifery.
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri © bioZhena Corporation From teen age to menopause.
Prof Lindeque Abnormal excessive uterine bleeding.
Part II: Menstrual Cycle. Facts about You As a fetus, you have more than 7 million eggs! At birth, 1-2 million are left At puberty, about 300,000 are.
Vaclav Kirsner, PhD, Founder CEO (970) Transforming Female Reproductive Health Management.
The multitude of repeatable measurable features of the cyclic pattern makes it possible to determine the boundaries of the fertile window for every individual.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Unit Circle - Radians Slide 1 Begin Slideshow Answer Next Previous To Navigate the Slideshow  Use the and arrows at the bottom of the screen to move between.
Vaclav Kirsner, PhD, Founder CEO
Folliculogenesis In Vivo™
Priorities Identified
Graphing Linear Equations
Vaclav Kirsner, PhD, Founder
To Navigate the Slideshow
Vaclav Kirsner, PhD, Founder
Abnormal Bleeding CAPT Mike Hughey, MC, USNR.
Primary Care Challenges in Depression - To Treat or Refer?
How do we delay disease progress once it has started?
(maturation of dominant follicle)
R.J. Fehring and W.D. Schlaff, J. Nurse-Midwifery 43 (2), 117, 1998
Fertility Assessment & Treatment
Technology Overview FOLLICULOGENESIS IN VIVO™
Startup version of the Ovulona cervical sensor has FDA clearance
Granting support access for individuals to Bill to IDs
Granting support access for individuals to contracts
Generating forms with the wizard in Access
Optimizing Efficiency + Funding
Technology Overview Revolutionary technology –
NON-BASELINE CYCLE WITH DELAYED OVULATION
Enter your text here Enter your text here.
Laptops and Windows tips
Epic Shortcuts This material contains confidential and copyrighted information of Epic Systems Corporation - Confidential.
Physician Diagnosis and Prescription
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri From teen age to menopause © bioZhena Corporation.
Epic Shortcuts.
Re-enabling Cisco’s ability to associate individuals to a Bill to ID
Private Placement Offering and/or Strategic Alliance Proposal
Special Issues of Women’s Health Care and Reproduction
To Navigate the Slideshow
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri From teen age to menopause © bioZhena Corporation.
Friendly Technology Data From Home To Healthcare Providers
To Navigate the Slideshow
Vaclav Kirsner, PhD, Founder
To Navigate the Slideshow
Ovulographic™ Technology
PREMENSTRUAL SYNDROME
What our FIV™ tech does for women and for family planning
(maturation of dominant follicle)
OvulonaTM detects delayed ovulation
Ovulona TM This personal monitor of cervix uteri is needed
What our FIV™ tech does for women and for family planning
From patients’ Ovulona™ units to a physician’s Ovulograph™
OvulonaTM monitors the end-organ effect of all reproductive effectors by measuring bioelectronic admittance of the outer-cervix tissue OvulonaTM basic.
Global revolution in cancer biomarkers real-time diagnostics
Vaclav Kirsner, PhD, Founder
Oregon HPV Summit - June 2019 Nasreen Abdullah, MD, MPH
Dysmenorrhoea.
Presentation transcript:

Ovulographic™ Technology Ovulographic™ Folliculogenesis In Vivo™ (FIV™) Data From Home To Healthcare Providers From patients’ Ovulona™ units to a physician’s Ovulograph™ – when needed Posterior Fornix

Ovulograph™ use for abnormal cycle diagnosis Baseline record flanked by two non-baseline records with abnormalities Abnormal = Delayed Ovulation Baseline cycle Abnormal = Short Luteal Phase Re: Delayed ovulation, see What is the mechanism of stress and how does it affect reproduction. Click on slide to go forward, or use navigation buttons in left bottom corner (or keyboard arrow keys) to navigate back and through the 4 slides

Ovulograph™ use example: symptometry Physicians can correlate symptoms with folliculogenesis to facilitate differential diagnosis. Here for PMS/PMDD vs. clinical depression.   The technology enables the input of symptometric and other auxiliary data in synchrony with the folliculogenesis data, which in turn enables the physician to provide a better medical help. This is unprecedented both in terms of providing the longitudinal cyclic profile data, and the correlated auxiliary data needed for effective diagnosis and treatment. (For example, the determination whether the COPE score rise is pre-ovulatory or post-ovulatory is essential for effective diagnosis of PMS/PMDD, currently not available .) Another auxiliary data is the background monitoring for tissue aberration, which will provide an innocuous and widely accessible screen for pathologies such as cervical cancer, significantly improving upon the current Pap smear screening. COPE = Calendar of Premenstrual Experiences Click on slide to go forward, or use navigation buttons in left bottom corner or keyboard arrow keys to navigate back and forth

Ovulona’s diagnostic power will save healthcare costs The absence of the two pre-ovulation peaks anticipates failure to ovulate. Ovulona™ anticipates Luteal Phase Defect (LPD), which too often causes failure to conceive by healthy women of any age Ovulona’s diagnostic power will save healthcare costs This cannot be matched by currently marketed ovulation prediction products